Spring 2016
“Being diagnosed with cancer and told that it may rule out parenthood can be devastating for people who haven’t yet started or completed their families,” says Terri Woodard, M.D., assistant professor of Gynecologic Oncology and Reproductive Medicine. Woodard directs MD Anderson’s Oncofertility Clinic.
At the Oncofertility Clinic, oncology and reproductive medicine
intersect to help cancer patients preserve fertility before treatment.
MD Anderson surgeons are adopting a program pioneered by their peers in
Europe that makes life easier for patients before, during and after surgery.
A new study is seeking new drugs to combat triple-negative breast
cancer, an aggressive form of the disease that doesn’t rely on the
hormones estrogen and progesterone or the protein HER2, which fuel the
growth of most breast cancers.
As a pediatric cancer clinician and researcher, Patrick Zweidler-McKay
has devoted his career to treating children with particularly difficult
or relapsed forms of cancer.
Thanks to teamwork and quick thinking, valuable cancer research was
saved when wildfires threatened the Smithville campus last October.
An oncologist and a surgeon from different hospitals work together to
treat primary cardiac sarcomas, aka heart tumors.
From the AIDS epidemic to fighting T cell lymphomas and skin cancer,
much of Madeleine Duvic’s work has dealt with these white blood cells.
Physicians and scientists are treating cancer by using their knowledge
of the cellular functions shared by it and other diseases.
Cord blood and half-match options provide patients with a whole lot of hope.
Cancer prevention experts weigh in on how to decrease your risk for
cancer by avoiding carcinogens on a daily basis.
MD Anderson researchers have recently published studies that point to a
connection between cancer and our diets and eating habits.
Cancer immunotherapy leaders at MD Anderson will work with experts at
five other cancer centers in a new alliance funded by the largest single
contribution ever made to the field.
Researchers with MD Anderson’s Colorectal Cancer Moon Shot are
sharpening the focus of a genetic tool designed to classify colorectal
cancer into one of four categories — a vital step toward improving treatment.